Showing results (51-60 of 136) with videos related to
Sort By:
Pageof 14
Cell Reports|November 23, 2017
CCR5 Directs the Mobilization of CD11b<sup>+</sup>Gr1<sup>+</sup>Ly6C<sup>low</sup> Polymorphonuclear Myeloid Cells from the Bone Marrow to the Blood to Support Tumor DevelopmentElias Hawila, Hila Razon, Gizi Wildbaum, et al.Plos One|April 23, 2014
Anti-VEGF-A affects the angiogenic properties of tumor-derived microparticlesMichal Munster, Ella Fremder, Valeria Miller, et al.Journal for Immunotherapy of Cancer|March 12, 2021
Host response to immune checkpoint inhibitors contributes to tumor aggressivenessIrina Khononov, Eyal Jacob, Ella Fremder, et al.Cancer Research|April 6, 2006
Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapyRaquel Munoz, Shan Man, Yuval Shaked, et al.Proceedings of the National Academy of Sciences of the United States of America|November 17, 2016
Heparanase is required for activation and function of macrophagesLilach Gutter-Kapon, Dror Alishekevitz, Yuval Shaked, et al.Drug Discovery Today|August 31, 2011
Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancerFrancesco Bertolini, Paola Marighetti, Ines Martin-Padura, et al.Nanotechnology|February 17, 2018
Copper oxide loaded PLGA nanospheres: towards a multifunctional nanoscale platform for ultrasound-based imaging and therapyOr Perlman, Iris S Weitz, Sarit S Sivan, et al.Cancer Research|June 3, 2004
A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimensUrban Emmenegger, Shan Man, Yuval Shaked, et al.The Journal of Cell Biology|July 28, 2025
STIM-IP3R crosstalk regulates migration of breast cancer cellsRuslana Militsin, Hadas Achildiev Cohen, Maya Hershfinkel, et al.Cancer Biology & Therapy|November 2, 2012
Porfimer-sodium (Photofrin-II) in combination with ionizing radiation inhibits tumor-initiating cell proliferation and improves glioblastoma treatment efficacyLiat Benayoun, Moshe Schaffer, Rotem Bril, et al.Pageof 14